C12N 2710/16732
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2710/16732 (Use of virus as therapeutic agent, other than vaccine) appears on 11 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 11
- Published applications
- 9
- Assignees
- 13
- Inventors
- 27
- Latest grant
- 26 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 3 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 2 |
| 2021 | 0 | 0 |
| 2022 | 2 | 1 |
| 2023 | 1 | 2 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pseudorabies virus for treating tumors26 Aug 2025US 12,397,027 B2Xiamen University
- Pharmaceutical composition comprising nanoperforator for preventing or treating viral infectious diseases3 Jan 2023US 11,541,100 B2Mvrix Co., Ltd.
- Non-neuroinvasive viruses and uses thereof20 Sep 2022US 11,447,753 B2Board of Regents of the University of Nebraska
- Non-neuroinvasive viruses and uses thereof24 May 2022US 11,339,378 B2Board of Regents of the University of Nebraska
- Non-neuroinvasive viruses and uses thereof12 May 2020US 10,647,964 B2Board of Regents of the University of Nebraska
- Herpesviral combination therapy for targeting cancer cells and cancer associated stromal cells11 Jun 2026US 2026/0158087 A1Mayo Foundation for Medical Education and Research
- Genetically Modified Bovine Herpesvirus Type 1 (BHV-1) for use to Treat Cancer27 Jul 2023US 2023/0233630 A1
- Non-neuroinvasive viruses and uses thereof16 Mar 2023US 2023/0082744 A1Board of Regents of the University of Nebraska
- Pseudorabies virus for treating tumors14 Apr 2022US 2022/0110988 A1Xiamen University
- Non-neuroinvasive viruses and uses thereof20 Aug 2020US 2020/0263146 A1Board of Regents of the University of Nebraska
Most cited
By later US patents
- Production of attenuated viruses7US 4,039,656 ABayer Aktiengesellschaft · 1977
- Treatment of infections in animals7US 4,049,794 ABayer Aktiengesellschaft · 1977
- Glycorproteins, antibodies, and diagnostic kits for detection of bovine herpesvirus type 14US 5,789,177 AStichting Centraal Diergeneeskundig Instituut · 1998
- Bovine herpesvirus type 1 deletion mutants and vaccines2US 5,676,951 AStichting Centraal Diergeneeskundig Instituut · 1997
- Non-neuroinvasive viruses and uses thereof1US 10,647,964 B2Board of Regents of the University of Nebraska · 2020